Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 1995 Aug;79(8):746-52.
doi: 10.1136/bjo.79.8.746.

Severe course of cutaneous melanoma associated paraneoplastic retinopathy

Affiliations
Case Reports

Severe course of cutaneous melanoma associated paraneoplastic retinopathy

U Kellner et al. Br J Ophthalmol. 1995 Aug.

Abstract

Background: Melanoma associated retinopathy (MAR) is a paraneoplastic syndrome in metastatic cutaneous melanoma presenting with nightblindness, light sensations, mild visual loss, and reduced b-waves in the electroretinogram (ERG).

Methods: A patient with MAR was followed for a period of 25 months with repeated examinations including visual field testing and recording of standard electro-oculography, standard ERG, and photopic On and Off responses.

Results: A male patient with a very severe course of MAR is described. In addition to the clinical signs seen in previous patients, severe visual deterioration and vitreous inflammation were the predominant signs. The vitreous inflammation resolved after systemic corticosteroid therapy. Nightblindness and the reduced b-waves in the ERG remained unchanged during the follow up period. However, further visual deterioration and paracentral scotomas developed. Dark adaptation was markedly abnormal. Photopic On responses were reduced, but Off responses were preserved. Antibodies against retinal bipolar cells were isolated from blood samples of this patient.

Conclusion: Vitreous inflammation may mask the diagnosis of MAR. ERG findings indicate that the more severe and progressive course is the result of local retinal changes and not progressive generalised retinal degeneration.

PubMed Disclaimer

References

    1. Arch Ophthalmol. 1986 Jul;104(7):1013-20 - PubMed
    1. Ophthalmology. 1994 Jul;101(7):1236-43 - PubMed
    1. Cancer. 1987 Aug 15;60(4):780-6 - PubMed
    1. Arch Ophthalmol. 1988 Aug;106(8):1035-7 - PubMed
    1. Am J Ophthalmol. 1988 Sep 15;106(3):307-11 - PubMed

Publication types

Substances